GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (LSE:ROQ) » Definitions » Cash Flow for Lease Financing

Roquefort Therapeutics (LSE:ROQ) Cash Flow for Lease Financing : £0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Roquefort Therapeutics Cash Flow for Lease Financing?

Roquefort Therapeutics's Cash Flow for Lease Financing for the six months ended in Dec. 2023 was £0.00 Mil. Roquefort Therapeutics's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00 Mil.

Compared with last quarter (£0.00 Mil in Jun. 2023 ), Roquefort Therapeutics's Cash Flow for Lease Financing remained the same in Dec. 2023 (£0.00 Mil).


Roquefort Therapeutics Cash Flow for Lease Financing Historical Data

The historical data trend for Roquefort Therapeutics's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Cash Flow for Lease Financing Chart

Roquefort Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Cash Flow for Lease Financing
- - -

Roquefort Therapeutics Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23
Cash Flow for Lease Financing - - - - -

Roquefort Therapeutics Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roquefort Therapeutics Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Roquefort Therapeutics (LSE:ROQ) Business Description

Traded in Other Exchanges
Address
85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses that are at an early stage in the medical sector including Drug and vaccine development; Diagnostics; Immuno-therapy; and Cell and gene therapies. The principal activity of the Company is to develop pre-clinical next generation medicines focused on hard to treat cancers.

Roquefort Therapeutics (LSE:ROQ) Headlines

No Headlines